Up-regulated GLT-1 Resists Glutamate Toxicity and Attenuates Glutamate-induced Calcium Loading in Cultured Neurocytes

Basic and Clinical Pharmacology and Toxicology

Volumn 112, Issue 1, 2013, Pages 19-24

  Liu, Chun Hua ^a   Jiao, Hong ^a   Guo, Zhao Hui ^b   Peng, Ying ^b   Wang, Wei Zhi ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CEFTRIAXONE; DIHYDROKAINIC ACID; GLUTAMIC ACID; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CELL DAMAGE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; EXCITOTOXICITY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; CALCIUM; CEFTRIAXONE; CELLS, CULTURED; CEREBRAL CORTEX; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; RATS; RATS, WISTAR; UP-REGULATION;

RATTUS;

EID: 84871132223     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12011     Document Type: Article

References (27)

1. Choi DW. Ionic dependence of glutamate neurotoxicity. J Neurosci 1987;7:369-79.
2. Möykkynen T, Korpi ER. Acute effects of ethanol on glutamate receptors. Basic Clin Pharmacol Toxicol 2012;111:4-13.
3. Maragakis NJ, Rothstein JD. Glutamate transporters: animal models to neurologic disease. Neurobiol Dis 2004;15:461-73.
4. Phillis JW, Ren J, O'Regan MH. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DLthreo-beta-benzyloxyaspartate. Brain Res 2000;868:105-12.
5. Lehre KP, Danbolt NC. The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain. J Neurosci 1998;18:8751-7.
6. Selkirk JV, Nottebaum LM, Vana AM, Verge GM, Mackay KB, Stiefel TH et al. Role of the GLT-1 subtype of glutamate trans-porter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus. Eur J Neurosci 2005;21:3217-28.
7. Beller JA, Gurkoff GG, Berman RF, Lyeth BG. Pharmacological enhancement of glutamate transport reduces excitotoxicity in vitro. Restor Neurol Neurosci 2011;29:331-46.
8. Miller BR, Dorner JL, Shou M, Sari Y, Barton SJ, Sengelaub DR et al. Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience 2008;153:329-37.
9. Robert H, Brown JD, Phil MD. Amyotrophic Lateral Sclerosis - A New Role for Old Drugs. N Engl J Med 2005;31:1376-8.
10. Hu Y, Li W, Lu L, Cai J, Xian X, Zhang M et al. An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats. Pain 2010;148:284-301.
11. Munch C, Zhu BG, Leven A, Stamm S, Einkorn H, Schwalenstocker B et al. Differential regulation of 5' splice variants of the glutamate transporter EAAT2 in an in vivo model of chemical hypoxia induced by 3-nitropropionic acid. J Neurosci Res 2003;71:819-25.
12. Allen NJ, Karadottir R, Attwell D. Reversal or reduction of glutamate and GABA transport in CNS pathology and therapy. Pflugers Arch 2004;449:132-42.
13. Maragakis NJ, Rothstein JD. Glutamate transporters: animal models to neurologic disease. Neurobiol Dis 2004;15:461-73.
14. Guillet B, Masmejean SLF, Samuel D, Samuel D, Nieoullon A, Pisano P. Developmental expression and activity of high affinity glutamate transporters in rat cortical primary cultures. Neurochem Int 2002;40:661-71.
15. Kim HG, Ju MS, Kim DH, Hong J, Cho SH, Cho KH et al. Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease. Basic Clin Pharmacol Toxicol 2010;107:958-64.
16. Han LP, Xu CQ, Jiang CM, Li H, Zhang W, Zhao Y et al. Effects of polyamines on apoptosis induced by simulated ischemia/reperfusion injury in cultured neonatal rat cardiomyocytes. Cell Biol Int 2007;31:1345-52.
17. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischaemic neuronal death. Annu Rev Neurosci 1990;13:171-82.
18. Sheldon AL, Robinson MB. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int 2007;51:333-55.
19. Phillis JW, Ren J, O'Regan MH. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DL-threo-beta-benzyloxyaspartate. Brain Res 2000;880:224.
20. Bonde C, Sarup A, Schousboe A, Gegelashvili G, Zimmer J, Noraberg J. Neurotoxic and neuroprotective effects of the glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) during physiological and ischemia-like conditions. Neurochem Int 2003;43:371-80.
21. Mitani A, Tanaka K. Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hip-pocampal CA1 of normal mice and mutant mice lacking GLT-1. J Neurosci 2003;23:7176-82.
22. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005;433:73-7.
23. Dawson LA, Djali S, Gonzales C, Viniegra MA, Zaleska MM. Characterization of transient focal ischemia-induced increases in extracellular glutamate and aspartate in spontaneously hypertensive rats. Brain Res Bull 2000;53:767-76.
24. Seki Y, Feustel PJ, Keller RW Jr, Tranmer BI, Kimelberg HK. Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker. Stroke 1999;30:433-40.
25. Lipski J, Wan CK, Bai JZ, Pi R, Li D, Donnelly D. Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience 2007;146:617-29.
26. Muller D, Toni N, Buchs PA, Parisi L, Stoppini L. Interface organotypic hippocampal slice cultures. In: Fedoroff S, Richardson A (eds). Protocols for neural cell culture. Totowa, NJ: Humana Press Inc, 2001;13-27.
27. Hartwick AT, Hamilton CM, Baldridge WH. Glutamatergic calcium dynamics and deregulation of rat retinal ganglion cells. J Physiol 2008;586:3425-46.